A survey indicates that 14% of adults worldwide report having severe headaches, while between 50% and 75% of adults worldwide suffer from migraines. Adults experiencing a migraine attack are treated with Maxalt throughout the headache phase. Following Maxalt treatment, the brain’s surrounding blood vessels swell less. This swelling causes the agony of a migraine attack.